News

Stocktwits on MSN52m
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy
Retail chatter around Klotho Neurosciences picked up late Thursday after the company said that the FDA had granted Orphan Drug Designation to its ALS gene therapy candidate, KLTO-202. The designation ...
TipRanks on MSN11h
Klotho Neurosciences Receives FDA Orphan Drug Designation
Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...
Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble?
Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.
Klotho Neurosciences stock soars after FDA grants orphan drug status for ALS
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus
U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...